Embryonic stem cells prevent developmental cardiac defects in mice.

Area of Science:

• Stem cell biology
• Developmental biology
• Cardiovascular research

Background:

• Embryonic stem cells (ESCs) show therapeutic potential for tissue repair.
• Cardiac defects in Id (inhibitor of DNA binding) gene knockout (KO) mouse embryos are lethal.
• Understanding ESCs' paracrine effects is crucial for regenerative medicine.

Purpose of the Study:

• To investigate the therapeutic potential of ESCs in correcting cardiac defects.
• To identify the secreted factors responsible for ESC-mediated cardiac repair.
• To elucidate the mechanisms by which ESCs influence gene expression in defective tissues.

Main Methods:

• Injection of ESCs into preimplantation Id KO mouse embryos.
• Analysis of cardiac morphology and gene expression profiles in treated embryos.
• Identification of secreted factors using biochemical assays.

Main Results:

• ESC injection into preimplantation embryos fully prevented cardiac defects and corrected gene expression in Id KO hearts.
• ESC injection into expectant mothers only partially rescued cardiac defects.
• Insulin-like growth factor I and Wnt5a were identified as key secreted factors mediating long-range and short-range effects, respectively.

Conclusions:

• ESCs possess a dual capacity to repopulate damaged tissue and secrete factors that correct cellular gene expression.
• Secreted factors like IGF-I and Wnt5a play critical roles in ESC-mediated cardiac repair.
• This research highlights novel therapeutic strategies for congenital heart defects using ESC-derived factors.